General Information of the Compound
| Compound ID |
CP0029201
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
GENZ-682452
Show/Hide
|
||||||||||||||||||
| Synonyms |
(3S)-1-Azabicyclo(2.2.2)octan-3-yl N-(2-(2-(4-fluorophenyl)-1,3-thiazol-4-yl)propan-2-yl)carbamate
(S)-Quinuclidin-3-yl (2-(2-(4-fluorophenyl)thiazol-4-yl)propan-2-yl)carbamate
1401090-53-6
AKOS027337125
BLP1XA3FZA
CS-6512
Carbamic acid, N-(1-(2-(4-fluorophenyl)-4-thiazolyl)-1-methylethyl)-, (3S)-1-azabicyclo(2.2.2)oct-3-yl ester
GZ-452
GZ4026
Ibiglustat
Ibiglustat [INN]
Ibiglustat(Genz-682452 pound(c)
SAR402671
SCHEMBL12615329
UNII-BLP1XA3FZA
Venglustat
YFHRCLAKZBDRHN-MRXNPFEDSA-N
ZINC202143443
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C20H24FN3O2S
|
||||||||||||||||||
| Molecular Weight |
389.496
|
||||||||||||||||||
| Canonical SMILES |
CC(C)(NC(=O)O[C@@H]1CN2CCC1CC2)c1csc(n1)-c1ccc(F)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C20H24FN3O2S/c1-20(2,17-12-27-18(22-17)14-3-5-15(21)6-4-14)23-19(25)26-16-11-24-9-7-13(16)8-10-24/h3-6,12-13,16H,7-11H2,1-2H3,(H,23,25)/t16-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
YFHRCLAKZBDRHN-MRXNPFEDSA-N
|
||||||||||||||||||
| CAS |
1401090-53-6
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Clinical Information about the Compound